About

Significant regulatory changes came along with the EU Medical Devices Regulation (MDR) 2017/745 (MDR) and evolutions affecting pre-clinical and clinical modules of medical device dossiers, their market approval process and notified bodies involved in the conformity assessment.

Also, due to research and innovation, the varieties of Device-Drug and Drug-Device Combination Products is growing and the MDR integrates a new process how to demonstrate compliance of integral device-drug combinations via Article 117.

This training gives you:

  • An overview of the requirements for combination products under the MDR.
  • Guidance through the regulatory conformity pathways for combination products.
  • Clear understanding of the regulatory requirements for devices containing medicinal substances, devices provided in combination with drug products, devices combining software and medicinal products, and devices associated with natural substances.
  • Hands-on insight on how to achieve compliance and the requirements for regulatory documentation and CE marking.

MODULE 1
Understanding combination products

  • Definitions in device and drug regulations.
  • How are combination products classified?
  • Separate worlds, however approaching.
  • Case studies.

Medical Devices Regulation 2017/745

  • Introduction to MDR.
  • Transition for industry and notified bodies.
  • Key changes for the industry.
  • Latest evoluations and next steps.

MODULE 2
Device conformity assessment

  • What is conformity assessment?
  • Process for CE marking and technical dossier and changes.
  • How to demonstrate compliance to safety and performance requirements (GSPR).
  • Case study – Syringe.

Device Drug combinations

  • Guidance and conformity assessment.
  • How is the European Medicines Agency (EMA) involved?
  • Technical documentation drug part.
  • Changes to the medicinal substance.

Drug Device combinations

  • Impact of MDR Article 117 and EMA Guidance.
  • Technical Documentation and Notified Body Opinion (NBO).
  • Device data in the drug CTD

Case studies / Q&A

This course is beneficial for professionals from both pharmaceutical and medical devices companies working in Quality Assurance, Regulatory Affairs, Clinical Operations, Medical Writing, Research & Development, CEO / CTO. The course will benefit to industry, pharma and biotech companies, CROs, Research Centres and Universities applied sciences and biotechnology faculties involved in development, manufacturing and sales of DDCPs.

Participant experience
Knowledge of the Medical Devices Directive (MDD 93/42) and of the Medical Devices Regulation (MDR) 2017/745 is an advantage. Newcomers are welcome.

The training includes knowledge transfer, interactive sessions, case studies and group discussions.

Lecturers
Arkan Zwick
Info

Arkan Zwick

Corporate Regulatory Affairs Director at CROMA Pharmaceutical, Austria

Mr. Arkan Zwick is Corporate Regulatory Affairs Director at a global pharmaceutical and surgical company active in ophthalmology, orthopedics, and aesthetic dermatology. With over 15 years of regulatory experience, he oversees EU compliance with notified bodies and manages global market authorizations across the Americas and Asia-Pacific. His expertise spans regulatory advocacy for drugs, medical devices, combination products, and cosmetics, as well as legal counsel on contracts, mergers & acquisitions, and intellectual property. Arkan holds a master’s degree in law and a PhD in European Law from the University of Vienna. He lectures in Vienna and speaks regularly at international conferences.


Online Training – 2 modules

MODULE 1 | 09 October 2025 from 09:30 am to 12:30 pm CEST
MODULE 2 | 10 October 2025 from 09:30 am to 12:30 pm CEST

After the registration, you will receive all details about the connection.

The course will proceed with a minimum number of participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.

Early Bird: € 680,00* (until 25 September 2025)

Ordinary: € 875,00*

Freelance – Individual – Academy – Public Administration: € 495,00*

* for Italian companies: +22% VAT

The fee includes: tuitions, organizational office assistance, teaching materials and attendance certificate that will be sent after the training via e-mail.

Register
Ordinary
Available until 08/10/2025
875,00
Freelance – Individual – Academy – Public Administration
Available until 08/10/2025
495,00
Clear

Ilaria Butta
Ilaria Butta
Events & Training Manager
Printable Version
At the end of the training, you will be able to
Risultato atteso
Understand the content of the MDR and its impact on the conformity assessment of devices.
Risultato atteso
Understand the requirements for combination products and the registration process to obtain CE marking and notified body option (NBO).
Risultato atteso
Understand the impact of Art. 117 MDR and gain practical experience on the life cycle of products.

<p>Online interactive training on Zoom platform.</p>
<p><em>LS Academy will provide the access link to the virtual platform a few days before the training.</em></p>

Online interactive training on Zoom platform.

LS Academy will provide the access link to the virtual platform a few days before the training.

<p>Online interactive training on Zoom platform.</p>
<p><em>LS Academy will provide the access link to the virtual platform a few days before the training.</em></p>